SCHEMBL12901052

SCHEMBL12901052

Cc1cc(Nc2ccccn2)c(C(F)(F)F)cn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
MAPK10 P53779 3/20 0.49
GFER P55789 1/20 0.49
ULK1 O75385 2/20 0.46
POLB P06746 1/20 0.42
MAPT P10636 1/20 0.42
APEX1 P27695 1/20 0.42
KDR P35968 1/20 0.42
LMNA P02545 1/20 0.41
LCK P06239 2/20 0.39
CYP1A2 P05177 2/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
TSHR P16473 1/20 0.38
CYP2C19 P33261 1/20 0.38
CTSC P53634 1/20 0.38
ALDH1A1 P00352 1/20 0.38
NPC1 O15118 1/20 0.38
CASP3 P42574 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12901771 0.85 MAPK10 (0.51) MEN1KMT2AMAPK10GFERULK1
SCHEMBL1230847 0.83 MEN1 (0.49) MEN1KMT2AMAPK10GFERULK1
SCHEMBL12901776 0.81 CYP1A2 (0.41) MEN1KMT2AMAPK10ULK1MAPT
SCHEMBL29689147 0.78 MAPK10 (0.53) MEN1KMT2AMAPK10GFERMAPT
SCHEMBL16035800 0.78 MAPK10 (0.53) MEN1KMT2AMAPK10GFERMAPT
SCHEMBL12901783 0.77 NPC1 (0.50) MAPTLMNACYP1A2CYP3A4CYP2C9
SCHEMBL12901062 0.76 KIF11 (0.50) MAPK10CYP1A2CYP3A4CYP2C9TSHR
SCHEMBL28688015 0.75 MAPK10 (0.53) MEN1KMT2AMAPK10GFERMAPT
SCHEMBL12900855 0.73 MAPK10 (0.45) MAPK10TSHRALDH1A1MAPK9
SCHEMBL12900857 0.73 NTRK1 (0.43) MEN1KMT2AMAPK10ULK1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110046121-A1 INHIBITORS OF FOCAL ADHESION KINASE THE SCRIPPS RESEARCH INSTITUTE (US) 2011-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110046121-A1 INHIBITORS OF FOCAL ADHESION KINASE PTK2, CABLES1, TNK2 MEN1 2909/4885KMT2A 1999/4885MAPK10 590/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.